Blood Cancer Research WA in Perth, Western Australia | Medical and health

Blood Cancer Research WA

Locality: Perth, Western Australia

Address: B Block, Hospital Avenue, Nedlands Perth, WA, Australia

Website: http://www.bloodcancerwa.org.au/

Likes: 638

Add/Update information

Reviews

Tags

• Medical and health
• Medical centre

25.01.2022 March is MYELOMA awareness month Myeloma is a type of blood cancer that currently has no cure. With the help of research, new treatment options can be offered to patients, and hopefully one day we can find a cure for this cruel cancer. Thats why Clinical Trials are vital for patients with blood cancer! ... #multiplemyelomaawarenessmonth #myeloma #research #clinicaltrials #bloodcancer #bloodcancerresearchwa #givingHOPEtoWestAustralia

24.01.2022 We are Blood Cancer Research WA #bloodcancerresearchwa #bcrwa #haematology #cancer #cancerresearch #clinicaltrials #bloodcancer #leaukaemia #lymphoma #myeloma #westernaustralia #perth

24.01.2022 It is disappointing to learn that the Medical Services Advisory Committee has not found in favour of funding tisagenlecleucel a chimeric antigen receptor T-cell... (CAR T-cell) therapy for diffuse large B-cell lymphoma (DLBCL). The committee felt that the evidence in support of the therapy was not as promising in DLBCL as it was in the paediatric population with acute lymphomblastic leukaemia. This leaves patients having to pay $600,000 for the treatment themselves. https://thelimbic.com//msac-rejection-of-car-t-cell-thera/

24.01.2022 The AMF13 trial has now been activated at LINEAR research institute, for those affected by T-Cell lymphoma. As a type of immunotherapy, AFM13 does not kill cancer cells directly but encourages the bodys own immune system to seek out and destroy the cells. It works by activating a type of immune cell, called a natural killer (NK) cell, and directing them to destroy the cancerous cells which harbour CD30, a molecule seen commonly on T-cell lymphoma cancer cells. When the natur...al killer cell is linked to the cancerous cell by AFM13 binding, its cell-killing ability is activated. This results in the bodys own immune cells destroying the cancer in a targeted manner. For further details on the trial, visit our Trials page on our website: https://www.bloodcancerwa.org.au/trials/ #bloodcancerresearchwa #bloodcancer #haematology #caner #lymphoma #clinicaltrials

23.01.2022 Exciting results published for patients with CHRONIC LYMPHOCYTIC LEUKAEMIA "Phase 1 study of selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL" Has just been published. Dr Gavin Cull, clinical and laboratory haematologist at Sir Charles Gairdner Hospital (SCGH) is the Principal Investigator of the Clinical Trial at SCGH, and also a co-author of the Publication, which uses Zanubrutinib.... Dr Cull (pictured) provided BCRWA with a quote about this exciting study: "This trial shows that zanubrutinib, a tablet taken twice daily, is very active in chronic lymphocytic leukaemia. The response rates were very high and the CLL came under good control in nearly all the patients. The good news for patients is that zanubrutinib was well tolerated with very few having to stop the tablets due to side-effects. While longer follow-up is needed, most patients remain on zanubrutinib with their CLL under very good control" The publication can be found here: http://www.bloodjournal.org///2019/07/24/blood.2019001160

23.01.2022 Blood Cancer Research WA would like to start this week with some positive news, by welcoming our new Lymphoma Clinical Nurse Consultant, Helena Furdas, to our team! Helena graduated from nursing at Curtin University in 2009 and shortly thereafter began her haematology experience in 2010 whilst working at Royal Perth Hospital on the Bone Marrow Transplant Unit. Since then she has continued to work in haematology and in 2015 transitioned with the State Centre for Allogeneic ste...m cell transplant to Fiona Stanley Hospital. Here she enjoyed working in the Cancer Centre providing care for patients to keep them well, happy and out of hospital. As the newest member of the team Helena is excited to be the Lymphoma CNC and looks forward to helping patients navigate their journey through lymphoma. #staysafe #bloodcancerresearchwa #bcrwa #bloodcancer #haematology #westernaustralia #perth

23.01.2022 Dr Bradley Augustson is a haematology consultant in Western Australia with a specialist interest in MYELOMA. Myeloma is a type of blood cancer that develops from plasma cells in the bone marrow. Myeloma is often called multiple myeloma because most people (90%) have multiple places in the body affected where bone marrow is normally active (i.e. within the bones of the spine, skull, pelvis, the rib cage, and the areas around the shoulders and hips). Currently there is no cur...e for myeloma. It is considered a chronic, relapsing and remitting disease, but with treatment it can be controlled for many years. More clinical trials are needed to keep up to date research and treatment options available for patients. #bloodcancerresearchwa #bcrwa #haematology #bloodcancer #myeloma #clinicaltrials #westernaustralia *follow us on Instagram @blood_cancer_research_wa

22.01.2022 Congratulations to Dr Carolyn Grove (Senior Lecturer and Clinical & Laboratory Haematologist) and Dr Xuan Tan (WA Haematology Research Fellow), who have been awarded grant funding by WA Healths Research Translational Project scheme to conduct a Research project Next Generation Sequencing in Chronic Lymphocytic Leukaemia and Acute Myeloid Leukaemia; A Health economic analysis Next generation sequencing (NGS) enables researchers to analyse genetics/DNA at a never-before seen... level. Dr Grove & Dr Tans project aims to analyse patients with newly diagnosed Chronic Lymphocytic Leukaemia and Acute Myeloid Leukaemia, to identify those patients who carry a genetic mutation; non-deletional TP53 mutation. NGS will be carried out on patients prior to treatment, to asses risk factors and aid treatment decisions (as patients with this particular genetic mutation often dont do well with standard chemo-immunotherapy). The intended outcome of this analysis is to help form a business case to include next generation sequencing in haematological malignancies to assist with improved prognostication and improving treatment selection, in particular avoiding futile treatment which carries significant side effects for patients #research #grantfunding #haematologyresearch #bloodcancer #westernaustralia #bloodcancerresearchwa

22.01.2022 Dr. Gavin Cull who is a clinical and laboratory haematologist at Sir Charles Gairdner Hospital has co-authored a very important study which compares the safety and efficacy of two highly effective drugs ibrutinib and zanubrutinib in treating patients with Waldenstrom’s Macroglobulinemia (WM). Below, Dr. Cull discusses the important findings this has for patients: Results of studies conducted at the Haematology Department, Sir Charles Gairdner Hospital, were published recentl...y in Blood journal and showed that zanubrutinib is a safe and very effective treatment for patients with WM. WM is a form of low grade lymphoma which involves the bone marrow and causes problems with low blood counts as it gets worse. The ASPEN study compared the efficacy and safety of ibrutinib, a first generation BTK-inhibitor, with zanubrutinib, a novel, highly selective BTK-inhibitor. While both drugs were highly effective in the treatment of WM, zanubrutinib was associated with less side-effects, including atrial fibrillation, and a trend toward better response quality. These results are consistent with the 3-year follow-up data of zanubrutinib in patients with WM, also published recently in Blood journal. Together, these studies confirm that zanubrutinib is a very effective treatment for patients with relapsed WM and is associated with a low incidence of side-effects. https://pubmed.ncbi.nlm.nih.gov/32731259/ https://www.bloodcancerwa.org.au

22.01.2022 In Dec 2019, Associate Professor Chan Cheah attended the annual ASH (American Society of Haematology) meeting. This global event, in malignant and non-malignant hematology, sees specialists from around the world attend and present on new and upcoming findings. @lymphomaaustralia interviewed A.Prof Cheah and you can find the first interview, on aggressive lymphoma, here: https://m.youtube.com/watch?v=4PNqEu8KI2Y #bloodcancerresearchwa #BCRWA #haematology #westernaustralia #ASH2019 #lymphoma

22.01.2022 On Friday, Blood Cancer Research WA were honoured to attend @worldsgreatestshave in Perth where (along with family & friends) we supported Haematology Clinical Trial Nurse, Trina, in her Big Shave! Trina really did brave the shave and we think her amazing smile says it all! Trina raised a whopping $3673.94 for @leukaemia_foundation and donated 11 plaits of 50cm length hair to be made into much needed wigs (Swipe to see her long locks before the shave!) *interesting fact* a...ll of the small shavings of hair from the Big Shave are made into Sea Mops which are used to mop up oil from the oceans. How cool is that!? Well done Trina! You have inspired us. Not only do you look incredible, you have done a wonderful thing for patients and families affected by blood cancer #leaukaemiafoundation #worldsgreatestshave #shavingtheworldfromcancer #bloodcancer #bloodcancernurse #bloodcancerpatient #bloodcancerresearchwa #westernaustralia #perth

21.01.2022 COVID-19 : Latest NMHS Advice People at Risk for Serious illness from COVID-19 Blood Cancer Research WA would like to share the latest advice from WAs North Metropolitan Health Service for people at risk during the COVID-19 pandemic. ... Please click on the link to view the information via our website https://www.bloodcancerwa.org.au/news/ #staysafe #nmhs #covid19 #bloodcancerresearchwa #bcrwa #hereforyou

20.01.2022 TOMORROW the amazing SCGH Haematology Clinical Trial Nurse, Trina, is braving the @worldsgreatestshave in support of @leukaemiafoundation and all of the cancer patients (and their families) that she cares for and supports. There is still time to Sponsor Trina and this wonderful cause! Please follow https://secure.leukaemiafoundation.org.au//FundraisingPage We will be there tomorrow to show our support and of course get some photos of Trinas Greatest Shave! ... #leaukaemiafoundation #worldsgreatestshave #bloodcancer #bloodcancernurses #bloodcancerpatients #bloodcancerresearchwa

20.01.2022 Blood Cancer Research WA have a vacancy! We are seeking to recruit a Haematology Clinical Research Fellow to work within our dedicated BCRWA team in Perth, Western Australia. The successful candidate will play a VITAL role in the function of a busy clinical trials unit, with studies ranging from phase I-III across lymphoma, myeloma and leukaemia. ... Come and work alongside a brilliant team and live in Australias best kept secret! CLOSING DATE: 15th March 2020 For the full Job Description and further details please visit the careers page on our website: https://www.bloodcancerwa.org.au/careers/ #bloodcancerresearchwa #bcrwa #haematologyfellow #research #perth #westernaustralia

19.01.2022 WA are in a great position globally right now but we need to continue to follow Government advice to keep it this way. Watch A/Prof Chan Cheahs latest video here, on COVID-19 for blood cancer patients.

18.01.2022 BLOOD, SWEAT AND TEARS OF JOY IN WESTERN AUSTRALIA On 24th October 2019, the Snowdome Foundation and Blood Cancer Research WA hosted Blood, Sweat and Tears of Joy an educational evening bringing together clinicians, researchers, patients and supporters. To read the full article on this inspiring and successful evening, please visit: ... https://www.bloodcancerwa.org.au//blood-sweat-and-tears-o/

17.01.2022 A little Friday message repost from @llsusa #cancer #bloodcancer #love #hope #spirit #bloodcancerresearchwa

16.01.2022 2019 was an amazing 1st year for Blood Cancer Research WA We DOUBLED the number of clinical trials open to patients in WA and we DOUBLED our target to help 30 new patients receive the latest & potentially life-saving treatments on clinical trials in 2019! In 2020 we will definitely be doing more of this . Plus... we have become #instagram active this year! Follow our journey: @blood_cancer_research_wa #bloodcancerresearchwa #BCRWA #bloodcancer #haematology #clinicaltrials

16.01.2022 Read the heartwarming and inspiring interview between @snowdomefoundation and WA clinical trial patient David. Its an article full of HOPE for blood cancer patients in West Australia

16.01.2022 CRSP-ONC-001 trial is now open at Sir Charles Gairdner Hospital This first-in-human trial will investigate the effectiveness and safety of CTX110, a chimeric antigen receptor (CAR) T cell therapy that includes genetically modified T-cells to treat relapsed and refractory B-cell malignancies. CTX110 targets CD-19, a protein expressed by B-cell malignancies that play an important role in activating and signalling b-cells. CTX-110 is a genetically modified off-the-shelf cellular immunotherapy product that can be delivered to patients quickly. The study is potentially suitable for patients with diffuse large B-cell lymphoma or B-cell acute lymphoblastic leukemia whose disease has relapsed following at least two previous treatments.

15.01.2022 As 2019 draws to a close, Blood Cancer Research WA (BCRWA) reflect on what a spectacular year we have had in Western Australia. BCRWA has seen its FIRST fully-functioning year and what a difference we have already made to blood cancer patients, by providing them with hope by being able to access Clinical Trials: - 21 haematology clinical trials are now currently open for patients in WA, compared to NINE in 2018 (as BCRWA launched)... -1st ever haematology clinical trial opened at Hollywood and has recruited NINE patients with AML (Acute Myeloid Leukaemia) - 57 patients have been recruited onto NINE clinical trials at LINEAR Clinical Research. Compared to ZERO before BCRWA began - 280 blood cancer patients are currently on clinical trials thanks to BCRWA! 2019 has been the greatest start to Blood Cancer Research WA that we could have wished for. We cannot wait to see what is achieved in 2020!! THANK YOU FOR YOUR CONTINUED SUPPORT

14.01.2022 Clinical Haematologist, Associate Professor Chan Cheah (Lymphoma Specialist and Director of Blood Cancer Research WA), provides an update for patients on COVID-19 with @lymphomaaustralia See their full video here: https://youtu.be/15NtCu2uS0I... Thank you to A.Prof Cheah & Lymphoma Australia for their time in creating this educational video, addressing some of the topics & questions most blood cancer patients are currently asking #bloodcancer #bloodcancerpatients #BCRWA #bloodcancerresearchwa #lymphomaAustralia #lymphoma #lymphomapatient #COVID19 #westernaustralia #perth

14.01.2022 BGB-11417-101: Latest Trial now open at LINEAR Research Institute! In humans, the BCL2 gene helps regulate cell death or life. A specific protein called Bcl-2 is pro-survival, helping to keep cells alive. Some cancer cells express to much BCL-2 protein, which reduces the cells death response. Over-expression of the protein is a common finding in leukaemias and lymphomas. This phase 1 study offers patients with mature B-Cell malignancies a tablet of BGB-11417 which is a Bcl-2 ...inhibitor. This drug is a 2nd generation Bcl-2 inhibitor, other Bcl-2 inhibitor currently used in lymphomas and leukaemias have shown very promising results. For more information about this trial, visit our website: www.bloodcancerwa.org/trials #cancer #bloodcancer #bloodcancerresearchwa #clinicaltrials #perth #westernaustralia #savinglives

13.01.2022 Professor Cheah featured on @9newsperth Prof Cheah raised awareness for blood cancer, encouraged participation in clinical trials and outlined the importance of clinical trials to develop more effective treatment options. ... Clinical trials prolong life, so participation is key! Please visit our website for more information about our current trials: https://www.bloodcancerwa.org.au/trials/ Please visit https://fundraising.snowdome.org.au/donations to help fund trials #bloodcancerresearchwa #Cancer #clinicaltrials #9newsperth

13.01.2022 Today is World Blood Cancer Day and these figures sadly speak for themselves. Blood Cancer Research WA are here helping those affected by blood cancer in Western Australia. We have doubled the number of available clinical trials since we launched in 2018, providing hundreds of patients access to the latest cancer treatments With your help, we can continue to offer WA patients opportunity and HOPE. Please support us on World Blood Cancer Day by donating to ‘WA blood canc...er research’: https://www.snowdome.org.au/donate/ . #WorldBloodCancerDay #bloodcancer #bloodcancerpatients #BloodCancerResearchWA #BCRWA #ClinicalTrials #haematology #HOPE See more

13.01.2022 Happy World Lymphoma awareness day from the team at Blood Cancer Research WA! Supporting WA patients with lymphoma L-R : Dr Kat Lewis - Fellow, Ms Helena Furdas - Lymphoma Clinical Nurse Consultant, Dr Elizabeth Smyth Fellow, Prof Chan Cheah. #WLAD2021 #lymSM

12.01.2022 It doesnt hurt to save a life 70% of blood cancer patients needing to find a matched stem cell/bone marrow donor to save their life, need to find an UNRELATED donor via the DONOR REGISTRY. YOU could be the match to SAVE SOMEONES LIFE. This weekend, do some amazing... sign up to save a life! ... (We just have) it takes seconds: https://strengthtogive.org. @strength2give #itdoesnthurttosavealife #strengthtogive #bethematch #australianbonemarrowregistry #savealife #bloodcancer #bloodcancerresearchwa #australia

12.01.2022 We know these are worrying times. We want the wider community and those at the highest risk to stay safe. Associate Professor Chan Cheah, Clinical Haematologist, has retweeted a link on our website (www.bloodcancerwa.org.au) from National Cancer Institute, with information for Cancer Patients: What people with cancer should know about #coronavirus from @theNCI. The page includes: ... - How you can protect yourself - If youre at higher risk - What you should do about getting your cancer treatment And more. #COVID19 https://www.cancer.gov/c/emergency-preparedness/coronavirus #covid19 #cancerpatients #bloodcancer #bloodcancerresearchwa

12.01.2022 A new major International study has just been published! COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study By Dr Allison Barraclough, who trained and worked in WA before recently relocating to Melbourne, and several collaborating co-authors (including four from Western Australia), which looked into gene-expression profiling and prognosis for patients with stage I/II Diffuse Large B-Cell Lymphoma (DLBCL). ... 211 patients were identified for this retrospective study across Sir Charles Gairdner Hospital, Hollywood Private Hospital, Princess Alexandra Hospital, British Columbia Centre for Lymphoid Cancer, Aalborg University Hospital, and Nottingham University Hospital. Key points of note: - In early-stage DLBCL, COO and DE/DH [gene expression] status may not confer an inferior prognosis. - Stage I/II DLBCL has an excellent outcome when treated with R-CHOPlike therapy radiation, with 4-year Progression Free Survival and Overall Survival rates of 85% and 88%. The full article can be viewed here: http://www.bloodadvances.org/content/3/13/2013

12.01.2022 The wonderful Snowdome Foundation have published a feature article on WAs inspirational Associate Professor Chan Cheah, who recently joined Snowdome at their annual Blood, Sweat and Tears of Joy event in Melbourne (pictured). Assoc Prof Chan Cheah is passionate and driven. He wants blood cancer patients in Western Australia to have the same opportunity to access new treatments as patients in other parts of Australia. He knows too well that without clinical trials a blo...od cancer patient will cycle through chemotherapy and radiotherapy, followed by immunotherapy and if you cant afford to move your life to Melbourne or Sydney there are no other options available. Read Snowdome Foundations full article here: https://www.snowdome.org.au//providing-access-to-blood-ca/ (Words & picture inset with thanks to Snowdome)

10.01.2022 04 Feb is World Cancer Day World cancer day aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease (UICC.org) 2020 calls to empower patients, survivors, health care professionals, the government and large organisations to act and commit to reduce the global impact of cancer, in their three year campaign: I am and I will. ... To find out more, head over to >> https://www.worldcancerday.org/

09.01.2022 Please check out this wonderful art exhibition happening TOMORROW. Raising much needed funds for charity including for Snowdome Foundation and Blood Cancer Research WA

09.01.2022 Help Trina reach her $2000 goal! On 13th March 2020, dedicated Sir Charles Gairdner Hospital Haematology Clinical Trial nurse, Trina, is SHAVING her hair in the @leukaemia_foundation @worldsgreatestshave!! Trina has been caring for cancer patients for 11 years. She has seen first hand how the leukaemia foundation can provide much needed emotional & physical support during those times of need. ... Now Trina needs YOUR help to reach her goal. Every $ counts! To read more about Trinas story and to DONATE, visit: https://secure.leukaemiafoundation.org.au//FundraisingPage #countdown #wordsgreatestshave #leukaemiafoundation #bloodcancer #cancernurse #dedication #sircharlesgairdnerhospital #westernaustralia

08.01.2022 Professor Cheah ranked in the top 0.1% of lymphoma researchers globally Professor Cheah has been ranked in the top 0.1% scholars globally in lymphoma research over the past decade by Expertscape. This achievement acknowledges Professor Cheah’s ongoing work helping blood cancer patients not only in Western Australia but across the world

07.01.2022 A big & warm welcome to our newest member of Blood Cancer Research WA - Andrea. Who joins us via Snowdome Foundation. We cant wait for the future and all of the hope we shall bring together

07.01.2022 OUR NEW WEB HOME We are thrilled to announce our website has a new look and is now LIVE! Head over to https://www.bloodcancerwa.org.au/ to check out the amazing research our team has been up to and keep up to date with our current clinical trials and news. ... #haem #BCRWA #clinicaltrials #research #2020 #news #savinglives #health

07.01.2022 Thank you Snowdome Foundation for your wonderful article on our newest member Helena #bloodcancerresearchwa #bcrwa #bloodcancer #lymphomaNurseSpecialist

05.01.2022 Do you or a loved one have chronic lymphocytic leukaemia? The ASSURE trial opened at Sir Charles Gairdner Hospital in Nov 2019 for patients with CLL. Chronic lymphocytic leukaemia, also called CLL, is a type of blood cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). CLL usually gets worse slowly and is one of the most common types of leukaemia in adults, often occurring during or after middle age.... Participants on ASSURE will receive an oral capsule of Acalabrutinib treatment for an intended 48 cycles (28 days per cycle). Head to our website >> www.bloodcancerwa.org.au/trails to read more about the trial

05.01.2022 20 May 2020 - International clinical trials day Today we celebrate the amazing feat that Clinical Trials are! Haematology Clinical trials offer blood cancer patients access to the latest and potentially life-saving treatments, that are not available as standard therapy. It was Associate Professor Chan Cheahs dream to offer more trials in WA and to give Western Australia patients HOPE. With Chans determination, the dedication of the Blood Cancer Research Team, our Steeri...ng Committee and wonderful Doctors & Nurses, the generous donations from our amazing supporters, and the extremely hard-working staff working across the Sites we collaborate with (SCGH, LINEAR and HPH).. this dream is becoming a reality for WA and we would like to dedicate today to them by saying THANK YOU! Today, there are 21 openly recruiting haematology clinical trials in WA (with many more active in treatment/follow-up phase)! As a comparison, there were only 9 trials open to recruitment the month before BCRWA launched in September 2018. More trials will be opening this year so please keep up-to-date with our website and follow us on Instagram & Facebook for the latest updates. As ever, we continue to needs funds to keep BCRWA running & to continue to make HOPE real for blood cancer patients in WA. Please donate to WA Blood Cancer Research if you can, via our wonderful supporter @snowdomefoundation who actively drive to make research a possibility in Australia: https://www.snowdome.org.au/donate *All donations are tax deductible and 100% of the donation is received by BCRWA* #internationalClinicalTrialsDay #haematologyClinicalTrials #bloodcancer #haematologyCancer #BloodCancerResearchWA #BCRWA #TeamWork #Supporters #ThankYou

04.01.2022 We have recently opened up two new clinical trials at Linear Clinical Research! Patients with B-Cell Lymphoma or Chronic lymphocytic leukemia will now have the opportunity to enrol into the trials ran by our superstars, Professor Chan Cheah and Dr. Katharine Lewis as PI of each study! MALT-1... BGB-3111-113 Find them on our website https://www.bloodcancerwa.org.au/ #clinicaltrials #WA #hope #BCRWA #bloodcancerresearchwa #raiseawareness #BTK #Beigene #Janssen #noveltherapies #treatment #zanubrutinib #CLL #lymphoma #linearclinicalresearch #support

04.01.2022 'BLOOD, SWEAT AND TEARS OF JOY' IN WESTERN AUSTRALIA On 24th October 2019, the Snowdome Foundation and Blood Cancer Research WA hosted Blood, Sweat and Tears of Joy an educational evening bringing together clinicians, researchers, patients and supporters. To read the full article on this inspiring and successful evening, please visit: ... https://www.bloodcancerwa.org.au//blood-sweat-and-tears-o/

03.01.2022 WA contributes to international study in Burkitt lymphoma Based on data gathered from 264 patients across six different countries, our latest publication highlights the effectiveness of multidrug immunotherapy for patients with Non-endemic Burkitt lymphoma. Immunotherapy promises favourable patient outcomes with improved survival rate, low relapse risk and lasting remission. #bloodcancerresearchwa #lymphoma #Cancer #immunotherapy... You can access this publication from: https://onlinelibrary.wiley.com/doi/10.1111/bjh.16425

03.01.2022 An exciting new trial for Treatment-Naive Follicular Lymphoma patients, is open at SCGH which trials a combination of three drugs, in place of standard chemotherapy: "LEVERAGE" Follicular lymphoma is a common type of lymphoma, with thousands of West Australians each year living with the disease. Associate Professor Chan Cheah, Consultant Haematologist in WA, has designed a new Clinical Trial which will see the evaluation of a novel combination of three drugs, in place of chem...otherapy (the existing standard treatment). This combination of treatments is designed to harness the immune system to target cancer cells, as well as priming them for self-destruction. The treatment is expected to be highly effective based and fewer side effects (such as hair loss, nerve damage and infections) compared with standard treatment, chemotherapy Visit our website for further information & contact details for the trial: www.bloodcancerwa.org.au

02.01.2022 What an exciting day it was yesterday for Dr Chan Cheah and his patient Robert, who is the very first patient on Dr Cheahs own clinical trial LEVERAGE. Dr Cheah has spent a few years designing the clinical trial, which will help treat patients with follicular lymphoma who are yet to receive any treatment for their blood cancer (treatment-naive). The trial opened in Sept 2019 and is currently recruiting patients. Please visit our website for further information: www.bloodcan...cerwa.org.au #clinicaltrial #LEVERAGE #bloodcancer #follicularlymphoma #BCRWA

02.01.2022 Some good news for WA patients - the ALLG NHL33 clinical trial is now open at Sir Charles Gairdner Hospital and will recruit newly diagnosed patients with Mantle Cell Lymphoma who are otherwise in good health and meet the eligibility criteria. Learn more about the trial: https://www.bloodcancerwa.org.au/trial/nhl33/ #clinicaltrials #mantlecelllymphoma #lymphoma #BCRWA #bloodcancer #research #westernaustralia #ALLG #NHL33 #hope #bloodcancerresearchwa #perth #cancer #leukaemiafoundationaustralia #health #chemotherapy #cancerawareness

02.01.2022 A.Prof Chan Cheah recently featured on 6PR where he discussed the important need for funding vital clinical trials, as well as for funding newer and more specific tests, such as genomics testing

01.01.2022 The first trial for EBV positive lymphoma patients is now available and will be recruiting at Sir Charles Gairdner Hospital, Perth! Australasian Leukaemia & Lymphoma Group - ALLG are the Sponsors of a new trial for Epstein Barr Virus (EBV) positive lymphoma patients: Trebl-1 (NHL31)... Lymphomas that are associated with viruses can be difficult to treat. Until now there are no treatments available that specifically target EBV. The new treatment is a combination of ibrutinib (oral capsule), rituximab (antibody), valaciclovir (anti-viral drug) and 3rd Party EBV-specific T cells (a type of white blood cell). It is hoped this research will demonstrate that the infusions, in combination with ibrutinib, will be a safe and effective therapy for EBV positive lymphoma patients. Visit: https://www.bloodcancerwa.org.au/trial/trebl-1-nhl31/ for further information on eligibility for the trial

01.01.2022 New publication: Integrated safety analysis of umbralisib, a dual PI3K/CK1 inhibitor, in relapsed/refractory lymphoid malignancies published in Blood Advances This latest publication, led by Dr Matthew Davids from Dana-Faber Cancer Institute is Boston, highlights the safety and efficacy of umbralisib, a new oral medication with a unique chemical structure that inhibits the enzyme PI3K and CK1 epsilon to decrease cancer cell growth among patients with relapsed/refractory ly...mphoid malignancies. The tolerable safety profile and low rates of immune-mediated toxicities associated with this medication strongly support its use among patients with B- cell malignancies. Prof Cheah was a co-author and all 3 BCRWA sites have been involved in clinical trials using umbralisib. #umbralisib #bloodcancerresearchwa You can access the publication from: https://ashpublications.org//Integrated-safety-analysis-of

01.01.2022 How incredible is Research and the dedicated Professionals who are all working to fight against blood cancer What an amazing discovery #bloodcancer #bloodcancerresearch #AML #bloodcancerresearchwa #snowdomeFoundation